NCT06673381 High Sensitive C-reactive Protein to Albumin Ratio in Acute Coronary Syndrome
| NCT ID | NCT06673381 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Acute Coronary Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 240 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2024-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 240 participants in total. It began in 2024-11-01 with a primary completion date of 2024-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients
Eligibility Criteria
Inclusion Criteria: * All patients aged 18 Year or older presented by ACS not candidet for primary percutaneus coronary intervention ( PCI ) . Exclusion Criteria: * • Patients aged \< 18 years old * Patients who have eGFR \<60 ml/kg /m2 * Patients who have malignancies * Patients who have chronic heart failure (NYHA class \>II) * Pateints who have chronic liver disease * Patients who have nephrotic syndrome * Patients who have acute cerebrovascular stroke * Pregnant women * Patients who have recent infection
Contact & Investigator
Amira Elbasuony, resident
PRINCIPAL INVESTIGATOR
Sohag University
Frequently Asked Questions
Who can join the NCT06673381 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06673381 currently recruiting?
Yes, NCT06673381 is actively recruiting participants. Contact the research team at amiraelbadawy518@gmail.com for enrollment information.
Where is the NCT06673381 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06673381 clinical trial?
NCT06673381 is sponsored by Sohag University. The principal investigator is Amira Elbasuony, resident at Sohag University. The trial plans to enroll 240 participants.